ARID5B and GATA3 SNPs have also been associated with an increased risk of relapse in childhood ALL patients (59, 71, 75), supporting that genetic variation in these genes also contributes to the inferior outcomes of Hispanic/Latino patients. This evidence concerns the gene GATA3 and acute lymphoblastic leukemia.